Paul Burton
Chief Tech/Sci/R&D Officer at AMGEN INC.
Net worth: 101 658 $ as of 2024-03-30
Profile
Dr. Paul Burton is a Chief Global Medical Affairs Officer at Janssen Pharmaceuticals, Inc. Dr. Burton was previously employed as a Vice President by Janssen Research & Development LLC. He received his graduate degree from the University of London and a doctorate degree from Imperial College London.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MODERNA, INC.
0.00% | 2022-11-06 | 954 ( 0.00% ) | 101 658 $ | 2024-03-30 |
Paul Burton active positions
| Companies | Position | Start |
|---|---|---|
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 2023-05-31 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Chief Tech/Sci/R&D Officer | 2020-02-29 |
| Royal College of Surgeons | Corporate Officer/Principal | - |
Former positions of Paul Burton
| Companies | Position | End |
|---|---|---|
| MODERNA, INC. | Chief Tech/Sci/R&D Officer | 2022-12-31 |
| JOHNSON & JOHNSON | Chief Tech/Sci/R&D Officer | - |
Janssen Research & Development LLC
 Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Corporate Officer/Principal | - |
Training of Paul Burton
| Imperial College London | Doctorate Degree |
| University of London | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| MODERNA, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Commercial Services |
- Stock Market
- Insiders
- Paul Burton
